News

MULTIMEDIA: Vemurafenib -- Melanoma Drug Cuts Death Risk

Publish date: August 10, 2011
By
Therese Borden

 

This drug works by attacking a specific genetic mutation, BRAF V600E, that accelerates tumor growth.

<a href="http://storify.com/taborden/vemurafenib-gives-melanoma-patients-new-hope" target="_blank">View "Vemurafenib" on Storify</a>

Recommended Reading

Cancer Survivors Lag in Care for Comorbid Conditions
MDedge Family Medicine
No Increased Acute Myeloid Leukemia Risk in First-Degree Relatives
MDedge Family Medicine
Study: Update Family History Every 5 to 10 Years
MDedge Family Medicine
Panel Backs Accelerated Approval of Brentuximab for Lymphomas
MDedge Family Medicine
Obesity, Estrogen Status Influence Breast Cancer Outcomes
MDedge Family Medicine
Triptorelin Cuts Early Menopause in Breast Cancer
MDedge Family Medicine
Intensified Temozolomide Fails to Hike Glioblastoma Survival
MDedge Family Medicine
Occult Sentinel Node Metastases Don't Impact Survival
MDedge Family Medicine
CAD Software Does Not Improve Mammogram Accuracy
MDedge Family Medicine
PSA screening isn’t “nonsense”—it saved my life
MDedge Family Medicine

Related Articles